<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>New Delhi Archivi - Contropiano</title>
	<atom:link href="https://contropiano.org/tag/new-delhi/feed" rel="self" type="application/rss+xml" />
	<link>https://contropiano.org/tag/new-delhi</link>
	<description>Giornale comunista online</description>
	<lastBuildDate>Tue, 02 Apr 2013 07:35:21 +0000</lastBuildDate>
	<language>it-IT</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>India: Novartis battuta sul farmaco anticancro low cost</title>
		<link>https://contropiano.org/news/scienza-news/2013/04/02/india-novartis-battuta-sul-farmaco-anticancro-low-cost-015589</link>
		
		<dc:creator><![CDATA[Marco Santopadre]]></dc:creator>
		<pubDate>Tue, 02 Apr 2013 07:35:21 +0000</pubDate>
				<category><![CDATA[Scienza]]></category>
		<category><![CDATA[brasile]]></category>
		<category><![CDATA[brevetti]]></category>
		<category><![CDATA[cancro]]></category>
		<category><![CDATA[Cina]]></category>
		<category><![CDATA[diritto alla salute]]></category>
		<category><![CDATA[farmaci]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[low cost]]></category>
		<category><![CDATA[medici senza frontiere]]></category>
		<category><![CDATA[New Delhi]]></category>
		<category><![CDATA[novartis]]></category>
		<category><![CDATA[proprietà intellettuale]]></category>
		<category><![CDATA[vandana shiva]]></category>
		<guid isPermaLink="false">http://contropiano.org/news/scienza-news/2013/04/02/india-novartis-battuta-sul-farmaco-anticancro-low-cost-015589</guid>

					<description><![CDATA[<p><span style="font-size: 14px;">L'India conferma la sua reputazione di 'farmacia dei poveri' e mette a segno un altro successo nella sua battaglia a favore della produzione di farmaci salvavita a basso costo a discapito degli interessi e dei profitti delle potenti multinazionali straniere.&#160;</span></p>
<p>L'articolo <a href="https://contropiano.org/news/scienza-news/2013/04/02/india-novartis-battuta-sul-farmaco-anticancro-low-cost-015589">India: Novartis battuta sul farmaco anticancro low cost</a> su <a href="https://contropiano.org">Contropiano</a>.</p>
]]></description>
		
		
		
			</item>
		<item>
		<title>Brics, potenze emergenti protagoniste</title>
		<link>https://contropiano.org/news/internazionale-news/2012/03/29/brics-potenze-emergenti-protagoniste-07844</link>
		
		<dc:creator><![CDATA[Redazione Contropiano]]></dc:creator>
		<pubDate>Thu, 29 Mar 2012 08:52:19 +0000</pubDate>
				<category><![CDATA[Internazionale]]></category>
		<category><![CDATA[banca mondiale]]></category>
		<category><![CDATA[brics]]></category>
		<category><![CDATA[crisi]]></category>
		<category><![CDATA[economia]]></category>
		<category><![CDATA[guerra]]></category>
		<category><![CDATA[Iran]]></category>
		<category><![CDATA[moneta]]></category>
		<category><![CDATA[New Delhi]]></category>
		<category><![CDATA[siria]]></category>
		<category><![CDATA[vertice]]></category>
		<guid isPermaLink="false">http://contropiano.org/news/internazionale-news/2012/03/29/brics-potenze-emergenti-protagoniste-07844</guid>

					<description><![CDATA[<p align="LEFT"><span face="Arial, sans-serif"><span size="2">Qualcosa sta cambiando seriamente nei rapporti di forza mondiali. Il vertice in corso a New Delhi tra Brasile, Russia, India, Cina, Sudafrica indica aspettative molto diverse da quelle di Usa, Unione Europea e Giappone. Una nuova moneta comune diversa dal dollaro, la presidenza della Banca Mondiale e un serio stop alle minacce contro Siria e Iran.</span></span></p>
<p>L'articolo <a href="https://contropiano.org/news/internazionale-news/2012/03/29/brics-potenze-emergenti-protagoniste-07844">Brics, potenze emergenti protagoniste</a> su <a href="https://contropiano.org">Contropiano</a>.</p>
]]></description>
		
		
		
			</item>
	</channel>
</rss>
